Graduate and postdoctoral fellowships available for research in kidney, urology and hematology (KUH-ART)

Request for Applications (RFA) UCLA KUH-ART 2021 (NIDDK U2C DK129496-01) The new UCLA Advanced Research Training Program in Benign Kidney, Urologic and Hematologic Disorders (KUH-ART) will support highly qualified graduate students and postdoctoral fellows from one of the four partnered institutions (UCLA, Cedars-Sinai, Charles R. Drew University, and Lundquist Institute at Harbor-UCLA) to conduct mentored research (basic, translational, computational or health services). The program is specifically designed to provide the next generation of researchers and clinicians the training they need to conduct research in the areas relevant to benign nephrology, urology and hematology.

The Award

UCLA KUH-ART Scholars will receive up to 3 years of funding or until receipt of another training award. Continued support in years 2 and 3 will be contingent on the scholar’s performance during the prior year(s). The award will cover the scholar’s salary, benefits and tuition per NIH guidelines.

Eligibility Requirements

  • 1) For graduate students, be enrolled in a graduate program; for postdoctoral fellows, possess a doctoral-level degree (e.g., MD, PhD, DDS, PharmD)
  • 2) Have a mentor at one of the four UCLA partnered institutions (UCLA, Cedars-Sinai, Charles R. Drew University, and Lundquist Institute at Harbor-UCLA)
  • 3) U.S. citizen, non-citizen national or permanent resident. Individuals on temporary or student visas are not eligible.
  • 4) Not be a PI on another training award that supports the salary (e.g. NIH F31 or F32)
  • Application

    Deadline: Rolling deadline starting on July 1, 2021 until the 2021-22 slots are filled out. Send application materials to Doug Smoot

    Application components include:
  • 1) NIH-formatted Biosketch of the candidate
  • 2) NIH-formatted Other Support page of the candidate
  • 3) Project description (1 page maximum) (bibliography not counted in 1 page)
  • 4) Career development plan (1 page maximum)
  • 5) Letter of support from the mentor(s) (1 page maximum)
  • 6) Mentor(s) NIH-formatted Biosketch
  • Candidate Interviews

    Selected candidates will be invited for an interview with the KUH-ART Selection Committee


    Contact Doug Smoot

Elizabeta Nemeth received an award from the International Bioiron Society

At the biennial conference of the International Bioiron Society, held in Heidelberg, Germany, May 5-10, 2019, our Elizabeta Nemeth received an award "for her pioneering work in unravelling the mechanism of hepcidin and ferroportin in health and disease and contribution to IBIS".

Veena Sangkhae and Debora Stefanova recognized for Best Oral Presentations at BioIron 2017

Veena Sangkhae and Debora Stefanova were selected from among a very competitive field of young scientists to receive awards for Best Oral Presentations at Bioiron 2017, in Los Angeles.

Our article featured on Blood cover

The article, also highlighted in an editorial, reports that hepcidin deficiency causes the appearance of non-transferrin bound iron (NTBI) in blood, thereby promoting gram-negative infections.

read more